Can a synthetic molecule mimic an extended protein interface? Peptide-oligourea foldamers mimic two histone epitopes recognized by anti-silencing function 1, an emerging and challenging target in oncology, with nanomolar affinity and cell permeability.
Extended protein-protein interfaces are challenging targets for synthetic ligands competing with endogenous partners, as most peptidomimetics target a single recognition motif. The histone chaperone anti-silencing function 1 (ASF1), involved in chromatin assembly and genome maintenance and an emerging target in oncology, illustrates this challenge: its essential interaction with the H3-H4 histone dimer spans two epitopes, an H3 α-helix and an H4 β-strand.
To target this interface, the Molecular Assemblies and Genome Integrity team at I2BC (Université Paris-Saclay, CEA, CNRS) joined forces with Gilles Guichard’s team at CBMN (Laboratoire de Chimie et Biologie des Membranes et Nanoobjets) and IECB (Institut Européen de Chimie et Biologie) in Bordeaux. Their approach combines peptide-oligourea foldamer chemistry and synthesis with molecular design, structural biology, and biophysical characterization. Foldamers are synthetic molecules mimicking structural features of proteins.
High-resolution crystal structures obtained with researchers at Synchrotron SOLEIL guided the design of peptidomimetics combining both histone epitopes. These foldamers reproduce the natural H3-H4 binding mode on ASF1, with affinities reaching 6 nanomolar, and resist degradation in human plasma. This optimized compound binds endogenous ASF1 in cell extracts. Cell biology studies with the PICCEL facility at the CEA Fontenay aux Roses (formerly PARi) demonstrated their cell permeability and antiproliferation activity.
Selected as a Very Important Paper (VIP) in Angewandte Chemie International Edition, this collaborative study highlights a strategy for targeting extended protein-protein interfaces. The resulting foldamers provide tools to investigate ASF1 function and may help target other challenging intracellular protein-protein interactions.
More information :
https://onlinelibrary.wiley.com/doi/10.1002/ange.4112426
Contact : Françoise Ochsenbein francoise.ochsenbein@i2bc.paris-saclay.fr
Your new post is loading...